Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

26 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Elan Drug Technologies Articles

Elan cashes in 76% chunk of its Alkermes stake for $381 million; Roche updates on Illumina bid

14 March 2012

Alkermes completes Elan DT buy; signs manufacturing deal

19 September 2011

Alkermes shareholders vote in favor of merger with Elan Drug Technology

9 September 2011

Elan Drug Tech to merge into Alkermes in $960 million deal to create CNS leader

9 May 2011

Elan plans to retire $500 million of debt; says time not right to sell EDT; updates on Alzheimer’s drug

10 August 2010

Elan again mulls hiving off its drug delivery business as separate unit; chairman to retire

20 April 2010

Elan reports smaller loss for 2009, predicting operating profit in 2010

11 February 2010

Showing 1-7 of 7 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS